How do I find out if I qualify for a arrhythmogenic right ventricular cardiomyopathy study in Minnesota?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Minnesota to take part?

Not necessarily. These studies have a site in Minnesota, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a arrhythmogenic right ventricular cardiomyopathy trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Minnesota

Arrhythmogenic Right Ventricular Cardiomyopathy clinical trials in Minnesota

We’re tracking 3 recruiting arrhythmogenic right ventricular cardiomyopathy studies with a site in Minnesota — including Phase 1 studies, each written for real people, not researchers.

Recruiting studies in Minnesota

NCT03049254Recruiting
Registry and blood/tissue study for certain sudden heart death causes
This study builds a registry and collection of samples to better understand families affected by sudden heart death and related heart rhythm problems that are not clearly caused by a heart attack. It may help researchers identify patterns and improve future care, and it offers a way for patients and families to contribute to research.
Rochester, MinnesotaAges Any age
NCT06228924RecruitingPhase 1
Gene therapy for ARVC with PKP2 mutation
This trial tests a new gene therapy called TN-401 for people with ARVC caused by a specific PKP2 gene mutation. The goal is to see if the treatment is safe and can help reduce dangerous heart rhythms.
Rochester, MinnesotaAges 18–65
NCT06311708Recruiting
PKP2-related heart condition natural history study
This study looks at how plakophilin 2 (PKP2)-related arrhythmogenic right ventricular cardiomyopathy (ARVC) progresses over time. You'll give blood samples to check for antibodies to a virus used in gene therapy, and help doctors understand the disease better.
Rochester, MinnesotaAges 14–65

Where these studies are running in Minnesota

Institutions with a site for the recruiting arrhythmogenic right ventricular cardiomyopathy studies listed above.

Mayo Clinic · 3 studies

What taking part in a arrhythmogenic right ventricular cardiomyopathy study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Common questions

Are there arrhythmogenic right ventricular cardiomyopathy clinical trials in Minnesota?: Yes. We're currently tracking 3 recruiting arrhythmogenic right ventricular cardiomyopathy studies with a site in Minnesota, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a arrhythmogenic right ventricular cardiomyopathy study in Minnesota?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Minnesota to take part?: Not necessarily. These studies have a site in Minnesota, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a arrhythmogenic right ventricular cardiomyopathy trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New arrhythmogenic right ventricular cardiomyopathy studies open in Minnesota regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.